Structural bioinformatics for rational drug design

Area of Science:

• Computational chemistry
• Bioinformatics
• Drug discovery

Background:

• Drug discovery is a lengthy, costly process.
• Advancements in bioinformatics and cheminformatics are transforming the field.
• Computational methods are increasingly vital for modern therapeutic development.

Purpose of the Study:

• To review the state-of-the-art in structural bioinformatics for rational drug design.
• To examine the impact of computational technologies on the drug development pipeline.
• To highlight future directions and address limitations in computational drug discovery.

Main Methods:

• Structure- and ligand-based virtual screening.
• Molecular dynamics simulations.
• Artificial intelligence (AI)-driven predictive models.

Main Results:

• Computational methods significantly enhance the accuracy and efficiency of exploring chemical spaces and optimizing drug candidates.
• AI and physics-based simulations improve predictions of binding affinity and toxicity.
• These technologies accelerate lead compound identification and refinement.

Conclusions:

• Structural bioinformatics and AI are indispensable tools in rational drug design, complementing experimental approaches.
• Despite challenges in accuracy and interpretability, computational methods are crucial for informed decision-making in early drug discovery.
• Successful applications demonstrate the potential of these technologies in developing novel inhibitors.